281 related articles for article (PubMed ID: 22424855)
1. Multicolor flow cytometry for evaluation of platelet surface antigens and activation markers.
van Velzen JF; Laros-van Gorkom BA; Pop GA; van Heerde WL
Thromb Res; 2012 Jul; 130(1):92-8. PubMed ID: 22424855
[TBL] [Abstract][Full Text] [Related]
2. Aspirin inhibits surface glycoprotein IIb/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets.
McKenzie ME; Malinin AI; Bell CR; Dzhanashvili A; Horowitz ED; Oshrine BR; Atar D; Serebruany VL
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):249-53. PubMed ID: 12695747
[TBL] [Abstract][Full Text] [Related]
3. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
[TBL] [Abstract][Full Text] [Related]
4. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
[TBL] [Abstract][Full Text] [Related]
5. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
[TBL] [Abstract][Full Text] [Related]
6. Mass Cytometry Reveals Distinct Platelet Subtypes in Healthy Subjects and Novel Alterations in Surface Glycoproteins in Glanzmann Thrombasthenia.
Blair TA; Michelson AD; Frelinger AL
Sci Rep; 2018 Jul; 8(1):10300. PubMed ID: 29985398
[TBL] [Abstract][Full Text] [Related]
7. Anti-thrombotic action of clopidogrel and P1(A1/A2) polymorphism of beta3 integrin in patients with coronary artery disease not being treated with aspirin.
Dropinski J; Musial J; Jakiela B; Wegrzyn W; Sanak M; Szczeklik A
Thromb Haemost; 2005 Dec; 94(6):1300-5. PubMed ID: 16411409
[TBL] [Abstract][Full Text] [Related]
8. Whole blood microvolume laser scanning cytometry for monitoring resting and activated platelets.
Wyant TL; Smith PC; Brown B; Kantor AB
Platelets; 2001 Aug; 12(5):309-18. PubMed ID: 11487384
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two platelet activation markers using flow cytometry after in vitro shear stress exposure of whole human blood.
Lu Q; Malinauskas RA
Artif Organs; 2011 Feb; 35(2):137-44. PubMed ID: 20946295
[TBL] [Abstract][Full Text] [Related]
10. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
[TBL] [Abstract][Full Text] [Related]
11. CD63 associates with the alphaIIb beta3 integrin-CD9 complex on the surface of activated platelets.
Israels SJ; McMillan-Ward EM; Easton J; Robertson C; McNicol A
Thromb Haemost; 2001 Jan; 85(1):134-41. PubMed ID: 11204565
[TBL] [Abstract][Full Text] [Related]
12. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.
Lev EI; Patel RT; Maresh KJ; Guthikonda S; Granada J; DeLao T; Bray PF; Kleiman NS
J Am Coll Cardiol; 2006 Jan; 47(1):27-33. PubMed ID: 16386660
[TBL] [Abstract][Full Text] [Related]
13. Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease.
Braun OO; Johnell M; Varenhorst C; James S; Brandt JT; Jakubowski JA; Winters KJ; Wallentin L; Erlinge D; Siegbahn A
Thromb Haemost; 2008 Oct; 100(4):626-33. PubMed ID: 18841285
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of platelet function by flow cytometry.
Michelson AD; Barnard MR; Krueger LA; Frelinger AL; Furman MI
Methods; 2000 Jul; 21(3):259-70. PubMed ID: 10873480
[TBL] [Abstract][Full Text] [Related]
15. Change of platelet activation markers using flow cytometry in patients with hematology/oncology disorders after transfusion.
Lim YA; Cho SR; Lee WG; Park JS; Kim SW
Platelets; 2008 Aug; 19(5):328-34. PubMed ID: 18791938
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of high residual platelet reactivity by flow cytometry for outcomes of ischemic stroke patients on clopidogrel therapy.
Qiu LN; Wang L; Li X; Han RF; Xia XS; Liu J
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1145-52. PubMed ID: 25869773
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of Glanzmann thrombasthenia by whole blood impedance analyzer (MEA) vs. light transmission aggregometry.
Albanyan A; Al-Musa A; AlNounou R; Al Zahrani H; Nasr R; AlJefri A; Saleh M; Malik A; Masmali H; Owaidah T
Int J Lab Hematol; 2015 Aug; 37(4):503-8. PubMed ID: 25537026
[TBL] [Abstract][Full Text] [Related]
18. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
[TBL] [Abstract][Full Text] [Related]
19. Stimulated Glanzmann's thrombasthenia platelets produced microvesicles. Microvesiculation correlates better to exposure of procoagulant surface than to activation of GPIIb-IIIa.
Holme PA; Solum NO; Brosstad F; Egberg N; Lindahl TL
Thromb Haemost; 1995 Dec; 74(6):1533-40. PubMed ID: 8772233
[TBL] [Abstract][Full Text] [Related]
20. Detection of activated platelets in canine blood by use of flow cytometry.
Wills TB; Wardrop KJ; Meyers KM
Am J Vet Res; 2006 Jan; 67(1):56-63. PubMed ID: 16426212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
